A new web site is fluff. What matters is updated test result info, inclusion of the N Assay, expansion of products to the secret party and sales results in current financials. There is nothing to support the prospects of a buyout. If the products are saleable and a track record is established then maybe a buyout could happen. I think we are a long way from that.